Guggenheim Issues Pessimistic Forecast for Tenet Healthcare (NYSE:THC) Stock Price

Tenet Healthcare (NYSE:THC) had its target price reduced by equities research analysts at Guggenheim from $252.00 to $242.00 in a report issued on Monday, MarketBeat reports. The brokerage currently has a “buy” rating on the stock. Guggenheim’s price target suggests a potential upside of 23.35% from the stock’s current price.

Other research analysts have also recently issued reports about the company. Stephens decreased their price objective on Tenet Healthcare from $275.00 to $260.00 and set an “overweight” rating on the stock in a report on Monday, May 4th. Robert W. Baird reduced their target price on Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 5th. Wall Street Zen lowered Tenet Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday. Barclays raised their price objective on Tenet Healthcare from $238.00 to $240.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 8th. Finally, KeyCorp decreased their target price on shares of Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating on the stock in a research report on Friday, May 1st. Eighteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, Tenet Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $244.84.

Tenet Healthcare Stock Up 0.9%

NYSE THC opened at $196.19 on Monday. The business’s fifty day simple moving average is $184.41 and its 200-day simple moving average is $197.39. The company has a quick ratio of 1.30, a current ratio of 1.36 and a debt-to-equity ratio of 1.96. The firm has a market cap of $16.90 billion, a PE ratio of 10.20, a P/E/G ratio of 1.61 and a beta of 1.27. Tenet Healthcare has a 52 week low of $146.60 and a 52 week high of $247.21.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings data on Thursday, April 30th. The company reported $4.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.21 by $0.61. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The firm had revenue of $5.37 billion during the quarter, compared to analysts’ expectations of $5.39 billion. During the same period last year, the business earned $4.36 earnings per share. Tenet Healthcare’s revenue was up 2.6% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, equities analysts anticipate that Tenet Healthcare will post 17.5 earnings per share for the current year.

Insider Buying and Selling at Tenet Healthcare

In other news, Director J Robert Kerrey sold 5,638 shares of Tenet Healthcare stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $174.52, for a total value of $983,943.76. Following the completion of the sale, the director directly owned 16,804 shares of the company’s stock, valued at approximately $2,932,634.08. The trade was a 25.12% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Nadja West sold 3,000 shares of the business’s stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total value of $532,050.00. Following the completion of the sale, the director owned 24,805 shares in the company, valued at $4,399,166.75. This represents a 10.79% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.97% of the company’s stock.

Institutional Investors Weigh In On Tenet Healthcare

Large investors have recently added to or reduced their stakes in the business. Norges Bank purchased a new position in Tenet Healthcare in the 4th quarter valued at approximately $248,494,000. Wellington Management Group LLP grew its stake in Tenet Healthcare by 1,114.2% during the 4th quarter. Wellington Management Group LLP now owns 1,135,801 shares of the company’s stock worth $225,706,000 after purchasing an additional 1,042,260 shares in the last quarter. Boston Partners increased its holdings in Tenet Healthcare by 38.8% during the 3rd quarter. Boston Partners now owns 3,147,555 shares of the company’s stock worth $638,958,000 after purchasing an additional 880,413 shares during the period. AQR Capital Management LLC raised its position in Tenet Healthcare by 62.3% in the 3rd quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company’s stock valued at $380,989,000 after purchasing an additional 720,160 shares in the last quarter. Finally, Alliancebernstein L.P. boosted its stake in shares of Tenet Healthcare by 375.7% in the 2nd quarter. Alliancebernstein L.P. now owns 790,254 shares of the company’s stock valued at $139,085,000 after buying an additional 624,125 shares during the period. 95.44% of the stock is owned by hedge funds and other institutional investors.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.